Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 4 studies | 25% ± 5% | |
neuron | 3 studies | 20% ± 6% | |
GABAergic neuron | 3 studies | 51% ± 2% | |
astrocyte | 3 studies | 25% ± 12% | |
glutamatergic neuron | 3 studies | 58% ± 3% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 3 studies | 45% ± 10% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
lung | 100% | 1878.86 | 578 / 578 | 100% | 13.21 | 1155 / 1155 |
esophagus | 100% | 1843.58 | 1444 / 1445 | 100% | 14.84 | 183 / 183 |
ovary | 100% | 2800.22 | 180 / 180 | 100% | 12.88 | 429 / 430 |
breast | 100% | 2529.72 | 459 / 459 | 99% | 17.89 | 1112 / 1118 |
prostate | 100% | 1752.87 | 245 / 245 | 99% | 11.72 | 499 / 502 |
brain | 99% | 1659.34 | 2608 / 2642 | 100% | 11.45 | 702 / 705 |
thymus | 100% | 1758.12 | 652 / 653 | 98% | 12.06 | 594 / 605 |
intestine | 100% | 1800.94 | 966 / 966 | 98% | 9.45 | 514 / 527 |
uterus | 100% | 2508.12 | 170 / 170 | 97% | 11.37 | 447 / 459 |
stomach | 100% | 1220.03 | 359 / 359 | 97% | 10.21 | 278 / 286 |
bladder | 100% | 1979.52 | 21 / 21 | 97% | 9.37 | 488 / 504 |
adrenal gland | 100% | 1938.76 | 258 / 258 | 97% | 12.45 | 222 / 230 |
kidney | 100% | 1170.72 | 89 / 89 | 94% | 12.17 | 844 / 901 |
pancreas | 93% | 661.96 | 306 / 328 | 99% | 12.65 | 176 / 178 |
skin | 100% | 2288.46 | 1803 / 1809 | 92% | 11.51 | 434 / 472 |
liver | 97% | 710.59 | 219 / 226 | 78% | 5.52 | 317 / 406 |
adipose | 100% | 2554.33 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 2470.14 | 1335 / 1335 | 0% | 0 | 0 / 0 |
spleen | 100% | 1724.51 | 241 / 241 | 0% | 0 | 0 / 0 |
muscle | 100% | 1106.76 | 800 / 803 | 0% | 0 | 0 / 0 |
heart | 98% | 1420.77 | 844 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 93% | 9.49 | 42 / 45 |
lymph node | 0% | 0 | 0 / 0 | 79% | 4.60 | 23 / 29 |
eye | 0% | 0 | 0 / 0 | 70% | 4.78 | 56 / 80 |
peripheral blood | 46% | 366.84 | 428 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0019221 | Biological process | cytokine-mediated signaling pathway |
GO_0016567 | Biological process | protein ubiquitination |
GO_0032715 | Biological process | negative regulation of interleukin-6 production |
GO_0009968 | Biological process | negative regulation of signal transduction |
GO_0032436 | Biological process | positive regulation of proteasomal ubiquitin-dependent protein catabolic process |
GO_0071638 | Biological process | negative regulation of monocyte chemotactic protein-1 production |
GO_0045629 | Biological process | negative regulation of T-helper 2 cell differentiation |
GO_0046854 | Biological process | phosphatidylinositol phosphate biosynthetic process |
GO_0071404 | Biological process | cellular response to low-density lipoprotein particle stimulus |
GO_0035556 | Biological process | intracellular signal transduction |
GO_0050728 | Biological process | negative regulation of inflammatory response |
GO_0007173 | Biological process | epidermal growth factor receptor signaling pathway |
GO_0097699 | Biological process | vascular endothelial cell response to fluid shear stress |
GO_0007175 | Biological process | negative regulation of epidermal growth factor-activated receptor activity |
GO_0045627 | Biological process | positive regulation of T-helper 1 cell differentiation |
GO_0007259 | Biological process | cell surface receptor signaling pathway via JAK-STAT |
GO_0005942 | Cellular component | phosphatidylinositol 3-kinase complex |
GO_0005829 | Cellular component | cytosol |
GO_0005154 | Molecular function | epidermal growth factor receptor binding |
GO_0046935 | Molecular function | 1-phosphatidylinositol-3-kinase regulator activity |
GO_0005515 | Molecular function | protein binding |
GO_0030971 | Molecular function | receptor tyrosine kinase binding |
Gene name | SOCS5 |
Protein name | Suppressor of cytokine signaling 5 (SOCS-5) (Cytokine-inducible SH2 protein 6) (CIS-6) (Cytokine-inducible SH2-containing protein 5) Suppressor of cytokine signaling 5 |
Synonyms | CISH5 CIS6 CISH6 KIAA0671 |
Description | FUNCTION: SOCS family proteins form part of a classical negative feedback system that regulates cytokine signal transduction. May be a substrate-recognition component of a SCF-like ECS (Elongin BC-CUL2/5-SOCS-box protein) E3 ubiquitin-protein ligase complex which mediates the ubiquitination and subsequent proteasomal degradation of target proteins. Inhibits for instance EGF signaling by mediating the degradation of the EGF receptor/EGFR. Involved in the regulation of T-helper cell differentiation by inhibiting of the IL4 signaling pathway which promotes differentiation into the Th2 phenotype. Can also partially inhibit IL6 and LIF signaling. . |
Accessions | O75159 A0A3B3ISP4 ENST00000394861.3 ENST00000650009.1 ENST00000306503.5 |